Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Nov 1;32(11):948-953.
doi: 10.1097/IJG.0000000000002296. Epub 2023 Aug 17.

Participant Experience Using Novel Perimetry Tests to Monitor Glaucoma Progression

Sandra E Freeman  1 , Sofia De Arrigunaga  1 , Joyce Kang  1 , Yan Zhao  1 , Ana M Roldán  1 , Michael M Lin  1 , Tobias Elze  1 , Daniel Liebman  1 , Dolly S Chang  2   3 , David S Friedman  1
Affiliations
Observational Study

Participant Experience Using Novel Perimetry Tests to Monitor Glaucoma Progression

Sandra E Freeman et al. J Glaucoma. .

Abstract

Prcis: Participant surveys taken after using tablet-based and smart visual function analyzer (SVFA) perimetry tests suggest that patients may prefer novel perimetry tests over traditional visual field machines.

Purpose: Compare patient experience using the IMOvifa SVFA and the tablet-based Melbourne Rapid Fields visual field (VF) tests to the Humphrey Field 24-2 Swedish Interactive Threshold Algorithm Standard.

Patients and methods: Prospective observational cohort study on adult participants with diagnoses of glaucoma suspect, ocular hypertension, or glaucoma. Participants attended 2 study visits ~3 months apart. During the first visit, participants were trained to use the 2 novel perimeters, took 1 test on both new devices and the Humphrey Field Analyzer, then were surveyed. Participants received tablets and performed weekly tablet VF tests at home between study visits. At the final study visit, participants re-took the VF tests and completed the same surveys.

Results: Eighty-one participants were surveyed twice. At the baseline survey, participants preferred the SVFA (71.7%) and tablet tests (69.2%) over the Humphrey VF. Most were willing to perform weekly monitoring at home on the SVFA (69.1%) and tablet (75.4%). Participants generally had a "very good" overall experience when testing on the SVFA (71.6%) and tablet (90.1%). At the final visit, fewer participants were willing to test on the tablet daily (23.5% to 9.9%; P = 0.02 for change) and more were willing to test monthly (18.5% to 33.3%; P = 0.03 for change).

Conclusion: Users reported a preference for novel VF devices. Overall participant experience using these devices was positive, supporting the feasibility of home monitoring of VFs from an experience perspective.

PubMed Disclaimer

Conflict of interest statement

Disclosure: D.S.F. receives research support from Genentech Inc. and has received speaking honoraria and travel expenses from Thea Pharmaceuticals. D.S.C. is employed by Genentech Inc. T.E. receives research support from Genentech Inc. The remaining authors declare no conflict of interest.

References

    1. Gedde SJ, Vinod K, Wright MM, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern®. Ophthalmology. 2021;128:P71–P150.
    1. Varma R, Lee PP, Goldberg I, et al. An assessment of the health and economic burdens of glaucoma. Am J Ophthalmol. 2011;152:515–522.
    1. Chauhan BC, Garway-Heath DF, Goni FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92:569–573.
    1. Vingrys AJ, Healey JK, Liew S, et al. Validation of a tablet as a tangent perimeter. Transl Vis Sci Technol. 2016;5:3.
    1. Prea SM, Kong YXG, Mehta A, et al. Six-month longitudinal comparison of a portable tablet perimeter with the Humphrey Field Analyzer. Am J Ophthalmol. 2018;190:9–16.

Publication types